Innovative Trajectory Analysis Reveals Dynamics and Risk Factors of Post‐Kidney Transplant Diabetes Mellitus in a French Cohort
- 19 March 2025
- journal article
- Published by Wiley in Clinical Transplantation
- Vol. 39 (3) , e70116
Abstract
Background and Hypothesis: Post‐transplant diabetes mellitus (PTDM) is a common, dynamic complication after kidney transplantation (KT) that may resolve over time. To better understand and prevent PTDM, we analyzed its prevalence, evolution, and influencing factors.Methods: Data from the French national ASTRE database at different post‐transplantation periods (P) were analyzed. PTDM was defined by fasting blood glucose (FBG) ≥1.26 g/L, HbA1c ≥ 6.5%, or the use of hypoglycemic medications in kidney transplant recipients without diabetes. Patient trajectories were identified using group‐based trajectory models (GBTM), and associated factors were examined.Results: Among 2898 patients, PTDM prevalence was 27.3% at P1 (>M2, ≤M6), 21.3% at P2 (>M6, ≤M18), 19.8% at P3 (>M18, ≤M30), and 19.9% at P4 (>M30, ≤M42). Analysis of 1825 patients identified four trajectories: no PTDM (67%), late‐onset PTDM (6%), remission after P1 (10%), and early, persistent PTDM (17%). Late‐onset PTDM was linked to history of cardiovascular disease, higher BMI at transplantation, HCV positive status, and weight gain. Early, persistent PTDM was associated with older age, higher BMI, HVC positive status, history of cardiovascular disease, and tacrolimus use. PTDM remission was linked to lower BMI. Corticosteroids contributed to both late‐onset and persistent PTDM, while switching between tacrolimus and cyclosporine did not significantly affect progression.Conclusion: This study confirmed the high prevalence and dynamic nature of PTDM after transplantation, emphasizing the critical role of pretransplant cardiovascular disease, BMI, and early post‐transplant weight gain in the onset or remission of PTDM.Keywords
This publication has 24 references indexed in Scilit:
- Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 DiabetesNew England Journal of Medicine, 2024
- International consensus on post-transplantation diabetes mellitusNephrology Dialysis Transplantation, 2024
- Prediabetes is a risk factor for cardiovascular disease following renal transplantationKidney International, 2019
- Variability in the leptin receptor gene and other risk factors for post-transplant diabetes mellitus in renal transplant recipientsAnnals of Medicine, 2019
- Post-transplant diabetes mellitus in patients with solid organ transplantsNature Reviews Endocrinology, 2019
- HbA1c levels at 90 days after renal transplantation in non-diabetic recipients predict de novo pre-diabetes and diabetes at 1 and 3 years after transplantationInternational Urology and Nephrology, 2018
- Clinical evolution of post-transplant diabetes mellitusNephrology Dialysis Transplantation, 2015
- Insulin Resistance after Renal TransplantationJournal of the American Society of Nephrology, 2004
- Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantationDiabetologia, 2004
- Diabetes Mellitus after Kidney Transplantation in the United StatesAmerican Journal of Transplantation, 2003